Skip to main content
. 2018 May 16;26(8):1234–1237. doi: 10.1038/s41431-018-0171-x
Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for mutations in the FOXE3 gene(s) in ⊠ diagnostic,
⊠ predictive and
⊠ prenatal settings and for
⊠ risk assessment in relatives.